Work

Imaging biomarkers of ramucirumab and olaratumab in patients with recurrent glioblastoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.2044

Authors: Jaishri O'Neill Blakeley, Joy D. Fisher, Frank S. Lieberman, Janine Lupo, Louis B. Nabors, Jason Crane, Patrick Y. Wen, Andre Cote, David M. Peereboom, Qiuting Wen, Timothy Francis Cloughesy, H. Ian Robins, Serena Desideri, Stuart A. Grossman, Xiaobu Ye, Sarah Nelson

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, UPMC Hillman Cancer Center, University of California, San Francisco, University of Alabama at Birmingham, Dana-Farber Cancer Institute, Cleveland Clinic, University of California, Los Angeles, University of Wisconsin–Madison, UW Health University Hospital

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603352736

Cites:

Cited by: 4

Related to: 10